SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019230
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:54
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 910497
2 ex10-1.htm EX-10.1 75800
3 ex31-1.htm EX-31.1 18556
4 ex31-2.htm EX-31.2 18800
5 ex32-1.htm EX-32.1 8578
6 ex32-2.htm EX-32.2 8794
  Complete submission text file 0001493152-24-019230.txt   5726065

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cdt-20240331.xsd EX-101.SCH 44235
8 XBRL CALCULATION FILE cdt-20240331_cal.xml EX-101.CAL 55228
9 XBRL DEFINITION FILE cdt-20240331_def.xml EX-101.DEF 229442
10 XBRL LABEL FILE cdt-20240331_lab.xml EX-101.LAB 358131
11 XBRL PRESENTATION FILE cdt-20240331_pre.xml EX-101.PRE 299994
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 862990
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 24944244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)